a b s t r a c t
The Neural Crest, a transient epithelium in vertebrate embryos, is the source of putative stem cells known to give rise to neuronal, glial and endocrine components of the peripheral (sensory, autonomic and enteric) nervous system (PNS) and pigment cells in the skin. The Neural Crest is also widely believed to be the source of mesectodermal derivatives (skeletogenic, odontogenic, connective tissue and smooth muscle mesenchyme) in the vertebrate head [see (Bronner and LeDouarin, 2012; Le Douarin, 2012; Le Douarin and Kalcheim, 1999) ; see also (Hörstadius, 1950; Weston, 1970) ]. This conventional understanding of the broad developmental potential of the Neural Crest has been challenged over the past few years (Breau et al., 2008; Lee et al., 2013a Lee et al., , 2013b Weston et al., 2004) , based on recognition that the definition of the embryonic epithelia that comprise the Neural Crest may be imprecise. Indeed, the definition of the embryonic tissues understood to constitute the Neural Crest has changed considerably since it was first described by Wilhelm His 150 years ago (His, 1868) . Today, the operational definition of the Neural Crest is inconsistent and functionally ambiguous. We believe that more precise definitions of the embryonic tissues involved in Neural Crest development would be useful to understand (1) the range of cellular phenotypes that actually segregate from it, (2) when this lineage diversification occurs, and (3) how diversification is regulated.
In this idiosyncratic review, we aim to explain our concerns with the current definitions in this field, and in the chiastic words of Samuel Johnson (1781), "… make new things familiar and familiar things new". 1 Then, we will try to distinguish the developmental events crucial to the regulation of Neural Crest development at both cranial and trunk axial levels of vertebrate embryos, and address some of the implicit assumptions that underlie the conventional interpretation of experimental results on the origin and fates of Neural Crest-derived cells. We hope our discussion will resolve some ambiguities regarding both the range of derivatives in the Neural Crest lineage and the conventional understanding that cranial mesectodermal derivatives share a common Neural Crest-derived lineage precursor with components of the PNS.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). "Theories have four stages of acceptance: i) This is worthless nonsense; ii) This is an interesting, but perverse, point of view, iii) This is true, but quite unimportant; and iv) I always said so." [from a book review by J.B.S. Haldane (Haldane, 1963) ]."
Historic Background
His (His, 1868) first recognized and described a distinct band of cells that lay between the dorsal neural tube and the epidermal epithelium at the neurula stage of avian embryo development. He operationally named this transient structure Zwischenstrang and suggested, from morphological studies, that its cells were the source of peripheral ganglia. Subsequently, Marshall (Marshall, 1879) named this domain of cells the Neural Crest. He described the Neural Crest as the "outgrowth" of cells formed by the fusion of the longitudinal "neural ridges" after they meet in the embryonic midline to form the neural tube (which he referred to as the "neural canal") and after the overlying epidermal epithelium (which he called the "external epiblast") separates from the neural tube. Importantly, Marshall explicitly distinguished the Neural Crest, which appears to be part of the dorsal epithelium of the nascent Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/developmentalbiology neural tube, from its antecedent, the paired neural ridges, what we now call the dorsal ridges of the embryonic neural folds. He described these ridges as the "reentering angle between the external epiblast and the neural canal"-clearly indicating that the folds included both epidermal and medullary (neural) epithelia. As we will discuss further in the Formation of the Neural Crest section, the Neural Crest might more accurately be considered a portion of the dorsal neural tube epithelium that forms after the paired neural folds fuse in the embryonic midline to create the neural tube and after the neural epithelium separates from the overlying epidermal epithelium.
Julia Platt is often credited as the first to suggest, 120 years ago, that the Neural Crest was the source of skeletal and connective tissue derivatives in the head of amphibian embryos (Hall, 1999 ). Platt's detailed histological descriptions (Platt, 1891a, b; Platt, 1893 Platt, , 1894 led her and a few others to infer that cells forming the cranial skeleton originated from a lateral epithelial domain of the embryonic neural folds. Her main point-that skeletogenic mesenchyme ("Mesectoderm") arose from ectodermal epithelium -caused a serious controversy in the field of comparative morphology. This controversy, nicely summarized by Landacre (Landacre, 1921) , arose because it contradicted a major tenet of the Germ Layer Theory, which had stipulated that mesoderm was the embryonic germ layer that produced skeletal and connective tissues, as well as muscle, blood and vascular tissues. Although Platt's audacious challenge to the classical Germ Layer Theory was manifestly deleterious to her scientific career, it is important to emphasize that she was not responsible for making the Neural Crest "famous" as the source of skeletogenic mesenchyme [see (Hall, 1999) ]. Rather, she seems to have claimed only that the ectoderm of the neural folds, including the dorsolateral and epibranchial epithelium, produces mesectodermal connective tissue as well as peripheral ganglia. 2 The assertion that the Neural Crest was the source of skeletogenic mesenchyme should, instead, more appropriately be attributed to the numerous pioneers in the newly emerging field of experimental embryology who undertook to establish the developmental fates of embryonic cells and map them to epithelial locations in developing embryos.
Fate-mapping
Various experimental approaches have been used to test the normal developmental fates of cells in early embryonic epithelial domains. The details and limitations of the classical cell marking and fate-mapping studies have been critically reviewed elsewhere (Le Douarin and Kalcheim, 1999; Weston, 1970) , but they all primarily used amphibian and avian embryos and employed one or more of the following three basic experimental procedures:
(1) surgically ablating specific embryonic regions followed by an assessment of the resulting structural lesions; (2) marking specific locations of embryonic epithelia with vital dyes or other extrinsically applied substances followed by analysis of the fates of marked cells; and (3) observing the fates of cells derived from transplanted tissues of embryonic donors whose cells had been labeled with intrinsic or applied markers. The validity of the inferences from all these procedures depends on the specificity of the marking method. Such specificity, in turn, depends on knowing accurately what tissues were ablated or transplanted, assuring that extrinsic markers were precisely applied to known embryonic locations and not transferred to adjacent cells, and finally, assuring that intrinsic markers were not expressed in tissues or regions other than the one designated. As we shall discuss below, problems of interpretation arise when these criteria are not fulfilled.
The experimental embryologists confirmed the various derivatives of putative Neural Crest, and their studies-including the controversial suggestion that Neural Crest derivatives included cranial (visceral arch) structures, odontoblasts, and osteoblasts of dermal bone-were considered in an influential descriptive paper by de Beer (de Beer, 1947) , who pronounced that such studies showed "unequivocally" that Neural Crest was the source of skeletogenic mesenchyme. He went on to name these putative crest-derived precursors "Ectomesenchyme". 3 These early experimental analyses of Neural Crest development culminated in Hörstadius' influential review (Hörstadius, 1950) , who summarized the work of his student Sellman and other workers who had mapped the developmental history and fates of the cells thought to originate from the Neural Crest of amphibian embryos.
It is important to recognize, however, that the original marked domains in all of the relevant fate-mapping studies included not only the Neural Crest itself, as described by Marshall (Marshall, 1879) , but also the adjacent, lateral non-neural epithelia of the neural folds (see Fig. 1 ). In his review (Hörstadius, 1950) , Hörstadius explicitly acknowledged the ambiguity of whether the Neural Crest was an outgrowth from the spinal cord or a separate rudiment, and noted discrepancies in the comparative morphology literature about the "position of the crest material in relation to the thick neural plate and the thinner presumptive epidermis." These discrepancies are illustrated in Fig. 2 . Significantly, Hörstadius followed Raven's (Raven, 1931) specific conclusion that the entire ectoderm of the dorsal neural fold (see Fig. 2A ) consists of presumptive Neural Crest cells, and explicitly dismissed potential problems of interpretation by asserting that "…these discrepancies are of minor importance for the experimental worker, as in any case crest cells in Urodeles at the stages used for operation are situated in the ridges that are extirpated or transplanted." This conclusion affected the interpretation of experiments in this field for the next half-century. Thus, in the years that followed Hörstadius' review, the operational definition of Neural Crest was implicitly changed to include not only the dorsal ridges of the neural epithelium but also the lateral non-neural epithelium of the embryonic neural folds. Subsequent "neo-classical" grafting studies (Johnston, 1966; Noden, 1975; Weston, 1963) largely confirmed the various derivatives that had previously been attributed to the trunk and cranial Neural Crest, and began to map more precisely the timing and pathways of the migration of Neural Crest-derived cellular precursors of these derivatives, using tritiated-thymidine as a precise and relatively durable marker of donor cell nuclei. Conforming with these earlier mapping studies in amphibian embryos, pharyngeal cartilages and dermal bone were seen to be populated by graft-derived cells at rostral axial levels but, where neural fold grafts at all axial levels gave rise to connective tissue derivatives, grafted tissues from trunk axial levels of amniote embryos failed to contribute cells to skeletogenic mesenchyme in the trunk. Fig. 1 . Classic marking, grafting and ablation studies involved both neural and non-neural epithelia of the embryonic neural folds. This figure, taken from Hörstadius' influential monograph, documents the fact that the classical fate-mapping studies did not distinguish derivatives originating from lateral non-neural epithelium of the neural folds and the Neural Crest, as originally defined (Marshall, 1879) . (A) Neural ridge staining with neutral red (coarse stippling) and Nile blue (fine stippling). (B) Open neuralplate stage with staining marks as in (A). The head neural ridge is divided into 8 zones. (C) Left side is the epidermal line of coalescence (broken line), line of coalescence of the brain (dotted line), and presumptive ectomesenchyme (hatched region). Right side marks zones 1-8, showing the position of presumptive anterior trabeculae (a.Trab), mandibular arch (Mand.a), hyoid arch (Hy.a.), and gill arches. Full lines, vital staining; broken lines, extirpation and transplantation experiments. (D) Stained ectomesenchyme migrating under the epidermis along the endomesodermal mandibular, hyoid, 1, 2, and 3 þ 4 gill arches. Source: Reproduced from S. Hörstadius (1950, p. 41) .
Fig. 2.
Participation of non-neural epithelium and the adjacent neural epithelium of the medullary (neural) plate of the neural fold has been ambiguous since the Neural Crest was first described in the classical descriptive embryology literature. This figure, taken from Hörstadius' historic monograph, illustrates the uncertainty about which ectodermal epithelial components were actually thought to comprise the putative Neural Crest. Eventually, the author declared (pp. 4-5) that the distinction was operationally irrelevant, since both tissues were involved in the experimental mapping procedures. Figure shows the position of Neural Crest material (dotted) of Ambystoma during neurulation using transverse sections. (A1-A4) according to Raven, Roux Arch. 1931:125; (B) Around the same time, Le Douarin and her colleagues introduced the use of a quail-specific nucleolar marker as a permanent way to distinguish donor-derived cells from host cells and tissues (Le Douarin, 1973 , 1969 Le Douarin and Barq, 1969) , and confirmed inferences about cell migration pathways and cell types attributed to trunk and cranial Neural Crest-derived cells. Their work, further validated by Noden's detailed inferences (Noden, 1975) , revealed that labeled grafts from rostral axial levels of avian embryos were able to produce skeletogenic mesenchyme, whereas labeled grafts from more caudal axial levels of the embryo did not do so. They went on to conclude that trunk Neural Crest-derived cells in amniote embryos had lost the skeletogenic ability that was present in anamniotes (Baker et al., 1997; Bronner and LeDouarin, 2012; Le Douarin, 2012; Le Lievre, 1978; Le Lievre and Le Douarin, 1975) , but this conclusion-as the reader is likely becoming aware -was based on the previous assumption that the tissues grafted at trunk axial levels were comparable to the tissues grafted at cranial levels.
It later became clear that, indeed, grafted tissues at trunk and cranial axial levels were not comparable: neural tube segments lacking non-neural epithelium had been transplanted in the trunk, whereas neural folds containing both neural and non-neural epithelium were transplanted at more rostral axial levels. And it was through the thorough critical analysis of these published diagrams ( Fig. 3 ) that it became apparent that the transition from grafts with skeletogenic ability to those without exactly corresponded to the levels where neural fold grafts in developmentally younger embryos could be operationally replaced by grafts of neural tube segments from which the non-neural epidermal epithelium had already separated from the dorsal neural tube epithelium. Based on this insight, Weston et al. (Weston et al., 2004) suggested more parsimonious inferences: (1) that tissues grafted at the two axial levels were not equivalent; and (2) that the skeletogenic ability of graft-derived cells correlated with the initial presence of non-neural epithelium-containing neural fold grafts and, conversely, the lack of skeletogenic ability by graft-derived cells resulted from the absence of such a non-neural epithelial component in the grafts of neural tubes.
The definition of "Neural Crest" has changed over time As first noted by Hill in 1920 [and published much later; (Hill and Watson, 1958) ], the idiomatic use of the name "Neural Crest" changed so that it included not only the epithelial domains in the dorsal neural folds but also the cells that "proliferate" from them. This proliferation is what we now know to be the developmentally regulated events of Epithelial-Mesenchymal Transition (EMT), a general, morphogenetic process that occurs at various times during development and in many embryonic tissues (see the EMT and the onset of cell migration section). Although EMT is definitely not unique to the Neural Crest epithelium, the molecular attributes of this process, such as Snail1 or Snail2 expression (Aybar et al., 2003) , have become the defining, yet perhaps misleading (see the Neural crest epithelium and lateral nonneural epithelium of neural folds are phenotypically distinct section), markers for "Neural Crest". Thus, the term "Neural Crest" came to be used to indicate both the epithelium of the neural fold and the mesenchymal cells that dispersed along defined migration pathways in the embryo after they emerged from this epithelium. Consequently, it became an ever more imprecise way to refer to migrating mesenchymal cells and their derivatives as well as the epithelium from which this mesenchyme derived. Such usage further obfuscated the neural lineages of cells derived from what we will later introduce as "Authentic" Neural Crest epithelium (see the Formation of the Neural Crest section) and, at the same time, implicitly ceded greater developmental potential to it. By ignoring the possible heterogeneity of the neural fold epithelium and defining the entire region as "Neural Crest", we and most other workers in the field eventually concluded that Neural Crestderived cells possessed remarkably broad developmental potential Fig. 3 . Details of grafting protocols reveal that donor-derived mesectodermal derivatives were present in host embryos when neural fold epithelium was transplanted, but were absent in host embryos when the graft lacked lateral non-neural epithelium. Operationally, orthotopic grafts of cephalic neural folds were performed in early embryos, before the neural folds had joined in the midline to form the neural tube. Conversely, orthotopic grafts of neural tube segments were performed at more posterior axial levels in older host embryos, after the neural tube segments from donor embryos had separated from overlying epidermis. Source: Reproduced from Le Lievre and Le Douarin (1975) with permission from Development, The Company of Biologists. (Le Douarin and Kalcheim, 1999; Weston, 1970 Weston, , 1991 , including pigment, neural, glial and endocrine cells, and various skeletogenic and connective tissue derivatives (fibroblasts, as well as smooth muscle, angiogenic, odontogenic, and corneal stromal cells). In the following sections, we describe more precisely how the Neural Crest domain is induced and the topology and the dynamic events occurring during neurulation in the junctional area between the non-neural and neural epithelium. It is through this process that we are prompted to redefine what actually constitutes the Neural Crest.
Formation of the Neural Crest

Induction of Neural Plate Border (NPB) epithelium
Following neural induction (reviewed by Groves and LaBonne, 2014; Harland, 1994) , the embryonic ectoderm consists of two morphologically distinct epithelial domains: the thickened neural epithelium (the neural or medullary plate) and a thinner, nonneural epithelium. More recent works suggest that planar signaling-possibly involving Bone Morphogenetic Protein [BMP; (Aybar et al., 2003) ]-establishes the Neural Crest potential within cells that reside at the boundary of the two epithelia (neural plate border, NPB) (Aybar and Mayor, 2002; Dickinson et al., 1995; Moury and Jacobson, 1989; Selleck and Bronner-Fraser, 1995; Trainor, 2005; Simões-Costa and Bronner, 2015) . Thus, when medullary epithelium is transplanted ectopically into areas of non-neural ectoderm, diagnostic markers of Neural Crest (neuronal and pigment cells) appear within the host epithelial tissue. It is noteworthy, however, that no cells characteristic of skeletogenic mesectoderm are recognized in the responding epithelium. This apparent discrepancy might suggest that the induction of ectodermal epithelial cells to acquire Neural Crest developmental potential is different from those developmental events that lead cells to acquire skeletogenic potential.
More recently, other molecular components of signaling pathways said to be involved in Neural Crest induction have been identified (Hong and Saint-Jeannet, 2007; Jones and Trainor, 2005; Monsoro-Burq et al., 2003) . In Xenopus, for example, FGF8 and Wnt 8 have been reported to play roles in this signaling (Hong et al., 2008) . But, again, it should be noted that the molecular markers used as assays to identify "Neural Crest"-such as Snail2 and Sox9-are, in fact, co-expressed in cells at the NPB and in neural folds that will undergo EMT. These issues, as well as the inductive mechanisms leading to skeletogenic mesenchyme in the head, will be explored next.
Morphogenetic events leading to segregation of NC epithelium
At the onset of neurulation, the edges of the neural plate begin to elevate in a rostral-to-caudal sequence to form the neural folds. As initially described by His (see above), the dorsal-most portions of the neural folds-the paired dorsal ridges-converge and fuse at the embryonic midline to form a closed neural tube. As part of this morphogenetic event, the lateral portion of the neural fold epithelium delaminates to form a separate epidermal epithelium overlying the neural tube (Duband and Thiery, 1982; Martins-Green, 1988; Tosney, 1982) . 4 After neural tube closure, a Neural Crest domain appears within the epithelium of the dorsal neural tube, and from this epithelial domain, Neural Crest-derived mesenchymal cells subsequently emerge as a result of the regulated events of EMT (see the EMT and the onset of cell migration section).
Although the morphogenetic events leading to neural tube formation are similar at all axial levels, the details of neural tube closure and the emergence of mesenchymal cells from the neural fold epithelia at rostral axial levels differ from what occurs in the trunk. Specifically, at rostral axial levels (generally considered to start at the hindbrain, roughly anterior to the fifth pair of somites), putative Neural Crest cells are thought to undergo EMT before the dorsal ridges of the neural fold fuse in the midline, therefore resulting in the emergence of mesenchymal cells from neural fold epithelium before the neural tube is formed. To complicate matters, the acute folding at the dorsal ridges during convergence of the rostral neural folds eventually causes the non-neural component of the structurally heterogeneous neural fold epithelium to be superimposed onto the neural epithelium. In early morphological descriptions (see, for example, Fig. 2 ), these superimposed layers were difficult to distinguish so the actual source of mesenchymal cells that emerged from these epithelia could not be ascertained.
Eventually, however, E-cadherin immunoreactivity provided an opportunity to distinguish the non-neural and neural epithelia of the neural fold, even when they were superimposed on each other prior to the fusion of the dorsal ridges (see Figs. 4 and 5) . Cadherins provide a specific adhesion mechanism that can mediate cell recognition and tissue segregation during morphogenesis (Edelman et al., 1983; Gumbiner, 2005; Takeichi, 1991) , and the properties and role of cadherin-mediated cell adhesion mechanisms have been thoroughly reviewed in the recent literature (McKeown et al., 2013; Taneyhill and Schiffmacher, 2013) . E-cadherin is initially expressed in both the lateral non-neural epithelium and in the neural plate, and is particularly concentrated at adherens junctions. At some time during neural fold elevation, however, E-cadherin is progressively down-regulated in the neural epithelium and replaced by N-cadherin, while the nonneural domain of the neural fold continues to express high levels of E-cadherin at the epithelial cell surfaces. Thus, as the paired dorsal ridges meet in the midline, cadherins characteristic of the two distinct epithelial domains presumably mediate not only fusion of the folds but also delamination of the two epithelia to form the dorsal neural tube epithelium separate from the overlying epidermal epithelium (Edelman et al., 1983; Gumbiner, 2005; Takeichi, 2011) .
Adhesion mechanisms within the dorsal neuroepithelium are subsequently modified so that cells with Neural Crest potential down-regulate N-cadherin function and establish adhesions mediated by type 2 cadherins. Some of these type 2 cadherins (cadherin-6, cadherin-7 and cadherin-11) are expressed by Neural Crest-derived cells and are associated with the segregation of a distinct, coherent domain of Neural Crest epithelium from the neural epithelium (Dady et al., 2012; Duband, 2006; Nakagawa and Takeichi, 1998; Taneyhill and Schiffmacher, 2013) . This has been noted in both chick and mouse embryos at trunk and cranial axial levels. In Xenopus, however, a switch from E-to N-cadherin operates at cranial levels only. Recent studies suggest that Ncadherin plays a major role in collective cell migration in cooperation with a chemotactic mechanism (Barriga et al., 2013; Theveneau et al., 2010 Theveneau et al., , 2013 . It is likely that, in all instances, cells that have dissociated from the Neural Crest epithelium exhibit weaker intercellular adhesion than when they resided within the neural epithelium, which subsequently facilitates their migrationindividually and collectively-following EMT (Nakagawa and Takeichi, 1998; Theveneau and Mayor, 2012; Thiery et al., 2012) .
As previously intimated, we will hereafter refer to this nascent epithelial domain in the dorsal neural tube as "Authentic Neural Crest". Authentic Neural Crest epithelium exists only transiently within the dorsal neural tube. As Neural Crest-derived cells emerge from this epithelium, basal laminae assemble and "punctuate" their structural separation from the polarized neural and epidermal epithelia [(Erickson and Weston, 1983; Tosney, 1978) ; for additional details, see Erickson and Perris (1993) ]. The formation of such basal laminae by the respective epithelia operationally enables embryos to be micro-dissected so that the distinct domain of Neural Crest-epithelium can be distinguished from neural and epidermal epithelia by scanning electron microscopy ( Fig. 6) .
Consistent with the inferred mechanisms to segregate authentic Neural Crest from neural tube epithelium, antibodies that block the function of the neural cell adhesion molecule (N-CAM) and N-cadherin have been reported to cause Neural Crest cells to detach from the neural epithelium and to self-associate as clusters, but not to initiate Neural Crest cell migration [ (Bronner-Fraser et al., 1992) ; see also the seminal review by Erickson and Perris (1993) ]. Likewise, when Neural Crest-derived cells that express type 2 cadherins are prevented from migrating by blocking the interaction between integrin subunits and fibronectin (FN), the cells form cohesive clusters and appear to re-express N-cadherin (Boucaut et al., 1984; Monier-Gavelle and Duband, 1997) . Indeed, in vitro studies using the S180 sarcoma cells have shown that signaling by trunk crest cell migration pathways is promoted when cells express cadherin-7 but abrogated when they express N-cadherin. Similarly, S180 cell aggregates spread as a cohesive sheet when expressing N-or E-cadherin but transform into mesenchymal-like migratory cells when expressing cadherin-7 in response to FN substrata. Force measurement assays further support these findings, showing that the strength of adhesion generated by cadherin-7 interactions cannot compete with FNintegrin-generated forces. However, FN-integrin interactions can be overcome by N-cadherin-mediated adhesive strength (Chu et al., 2006; Dufour et al., 1999; Martinez-Rico et al., 2010) .
Parenthetically, this kind of selective adhesion among newly segregated Neural Crest cells resembles the clustering of Neural Crest-derived cells from explanted segments of avian neural tubes on culture substrates that do not support attachment or cell dispersal Loring et al., 1981) . The molecular basis for this cohesive behavior was not considered at the time but, in retrospect, it is tempting to suggest that new adhesive mechanisms involving type 2 cadherins help establish Neural Crest cell-specific adhesive affinities that are distinct from their previous neuroepithelial adhesions. This idea remains to be tested but, as discussed in the Fate-restriction and lineage diversification in Neural Crest-derived and Metablast-derived cell populations section, these enriched populations of Neural Crest-derived cells do provide useful opportunities to identify the presence of developmentally distinct subpopulations that are initially present in the clusters and, ultimately, to understand how environmental factors affect their subsequent fate Vogel and Weston, 1988) .
In any case, the partitioning of Neural Crest identity within the dorsal neural tube epithelium and the emergence of authentic Neural Crest-derived cells from this epithelium (discussed further in the following section) appear to be independently regulated developmental events. Whatever the mechanisms, these events occur after the non-neural epithelium of the neural fold separates to form the distinct epidermal epithelium overlying the neural tube, and do not involve the lateral non-neural epithelium of the neural fold.
EMT and the onset of cell migration
Genetic Regulation of EMT EMT-the process by which cells dissociate from an epithelium -is a precisely, yet complexly, regulated event that occurs in many epithelia during embryogenesis, wound healing and in cancer metastasis (Ahlstrom and Erickson, 2009; Lim and Thiery, 2012; Thiery et al., 2009) . EMT in the Neural Crest epithelium (Duband et al., 1995) coincides with, and is presumably controlled by, the expression of a number of regulatory genes in epithelial cells. These genes include members of the Snail family, which are thought to control the down-regulation of cadherins (Aybar et al., 2003; Nieto et al., 1994) . In turn, the expression of the Snail family genes is responsive to a regulatory pathway that includes Zeb-2, NF-κB, and Twist-1 (De Craene and Berx, 2013; Lim and Thiery, 2012; Nieto, 2002; Peinado et al., 2007; Thiery et al., 2009; Zhang and Klymkowsky, 2009 ), and some of these genes are suppressed by the Grainyhead-like (GRHL2) gene product [see Fig. 7 ; (Cieply et al., 2013 (Cieply et al., , 2012 ]. Because they are also expressed in the lateral neural fold epithelium and, subsequently, in mesenchymal cells that dissociate from the neural fold as well as Neural Crest epithelium, these two epithelial domains have been conflated, and many of these genes have been called "Neural Crest specifiers" (Meulemans and Bronner-Fraser, 2004; Sauka-Spengler and Bronner-Fraser, 2008) . It is important to note, however, that these genes are also expressed in different combinations during other EMT events in embryos, including the formation of mesoderm during gastrulation and during the emergence of sclerotome mesenchyme from epithelial somites; thus, the usefulness of denoting these genetic markers as unique indicators of Neural Crest identity is not clear. . Regulation of EMT involves multiple molecular components on several interacting pathways. In this suggested scheme the Grainyhead-like gene 2 and ZEB1 reciprocally inhibit each other. Such a regulatory loop allows fine tuning of EMT. GRHL2 function is also controlled by other genes expressed in epithelial cells that undergo EMT. Source: Adapted from Cieply et al. (2012 Cieply et al. ( , 2013 .
Regulation of cell migration in embryonic interstitial spaces
Tissue plasminogen activator (PA) (Erickson and Isseroff, 1989 ) and matrix metalloproteases [MMPs; for example, members of the ADAMs family (Alfandari et al., 1997; Duong and Erickson, 2004; Hall and Erickson, 2003) ] are also expressed in Neural Crest-derived cells, and are thought to modulate cell attachment and locomotion in matrixfilled interstitial spaces, and thereby function as inhibitors or promoters of EMT and cell locomotion. PA is produced by most cells that invade extracellular matrix (ECM)-filled interstitial spaces, and is part of an elaborate system regulating localized proteolysis associated with the cells' invasive properties (Menoud et al., 1989; Theuring et al., 1995; Valinsky and Le Douarin, 1985) . A promoter of human tissue PA (Ht-PA) has been exploited to drive Cre-recombinase in transgenic mice and, thereby to mark putative migrating Neural Crest-derived cells (Pietri et al., 2003) . However, since MMPs are expressed by somitic mesoderm cells as well as by mesenchymal cells in the branchial arches (see Fig. 8 ), neither they nor PA unequivocally indicates that such cells originate from Neural Crest epithelium. Like molecular markers of EMT, they are, in fact, attributes of cells undergoing morphogenetic events, regardless of their embryonic tissue of origin. Unfortunately, the fact that such in situ expression patterns have been widely adopted as early markers of Neural Crest-derived cells has made it difficult to consider the possibility that some lineages originated in a developmentally distinct epithelial domain within the neural folds [see below; and Weston et al. (2004) ].
As indicated earlier, cells that have undergone EMT from the dorsal epithelium of the trunk neural tube subsequently enter the adjacent, matrix-filled interstitial spaces that we have called the Migration Staging Areas [MSAs; (Weston, 1991) ; Fig. 9 ]. In the trunk, the MSA is delimited by the basal laminae of the epidermal epithelium, the neural tube, and the epithelial somites. A similar, larger matrix-filled interstitial space also exists as a potential MSA at cranial axial levels (Wehrle-Haller and but this space lacks the epithelial component and associated basal lamina provided in the trunk by mesodermally derived somites. Initially, at both cranial and trunk axial levels, these interstitial spaces contain large, hydrated ECM glycosaminoglycans (GAGs), such as hyaluronan, and various proteoglycan macromolecules (Pratt et al., 1975; Toole and Underhill, 1983; Weston, 1983; Yamada, 1983a) . It also contains basal lamina-associated proteins, such as laminin and FN (Perris and Perissinotto, 2000) . Eventually, in avian and mammalian embryos, sclerotome cells formed by EMT from the epithelial somites also deposit FN in the ECM of the trunk MSA. This matrix component then provides a substratum known to be used by Neural Crest-derived cells for locomotion (Newgreen and Thiery, 1980; Newgreen et al., 1982; Rovasio et al., 1983; Yamada, 1983b) . Direct observations of Neural Crest-derived cells in zebrafish embryos suggest that similar-but not identical-changes in somite structure precede Neural Crest cell dispersal on interstitial migration pathways (Eisen and Weston, 1993; Raible et al., 1992) .
Cells undergo precocious EMT from lateral non-neural epithelium of the Cranial Neural Folds
As previously mentioned, putative cranial Neural Crest-derived cells in amniote (e.g., mammalian and avian) embryos are generally thought to emerge sooner than trunk Neural Crest-derived cells-before the approximation and fusion of the dorsal ridges of the cranial neural folds in the midline to form brain "neuromeres" and before the subsequent segregation of Neural Crest epithelium from the dorsal neuroepithelium of the nascent neural tube. This inference, however, was based on the "classical" operational definition of Neural Crest, which included both the dorsal ridges and the lateral non-neural epithelium of the neural fold. It is important to recognize that, unlike in the trunk MSA, there is no somite epithelium at rostral axial levels to help establish favorable conditions for the migration of crest-derived cells into such an interstitial space. Consequently, before newly emerged Neural Crest-derived mesenchyme enters the cranial MSA, this large interstitial space lacks the mesodermally derived fibroblasts that are considered to be the source of interstitial FN in the trunk ECM. Instead, before Neural Crest-derived cells enter the cranial MSA, the function of such fibroblastic cells appears to be subsumed by the subpopulation of cells resembling sclerotome fibroblasts that, as we will discuss in the Neural Crest epithelium and lateral nonneural epithelium of neural folds are phenotypically distinct section, emerge only from explanted cranial neural fold epithelium in vitro and that are not present in cultures of explanted trunk neural tube explants under identical culture conditions [ (Newgreen and Thiery, 1980) ; see above and Breau et al. (2008); Weston et al. (2004)]. Importantly, the morphology of this FN-producing fibroblastic cell population differs significantly from the small stellate appearance of "authentic" Neural Crest-derived cells under identical culture conditions, and these fibroblastic cells appear to emerge precociously (before Neural Crest-derived cells have segregated from the dorsal neural epithelium) from the lateral non-neural epithelium of the Neural Fold (see .
The neural fold origin of such mesenchyme was initially inferred by Nichols (Nichols, 1981 (Nichols, , 1986 , who showed that cranial mesenchymal cells in mammalian embryos were specifically and differentially stained by Toluidine blue only when matrix GAGs had been precipitated in situ by the presence of cetyl-pyridinium chloride (CPC) in the histological fixative [see Pratt et al. (1975) ]. Remarkably, these cells were seen adjacent to the lateral neural fold epithelium ( Fig. 10 ) beginning when the neural folds were splayed open ventrolaterally, and more selectively stained cells were observed as the neural folds elevated medio-dorsally. Careful analysis of the appearance of the folds at progressive stages of elevation suggested that newly emerged mesenchymal cells were from the neural fold epithelium and were left behind as the folds continued to elevate. Thus, as a consequence of these morphogenetic events, mesenchymal cells seem to array in a progressive manner such that the earliest cells to emerge are located in the most ventral locations, and lateremerging cells in more dorsal locations. It is important to note, moreover, that the ventral-to-dorsal distribution of mesenchymal cells is accomplished well before the dorsal ridges of the neural folds meet in the midline and fuse to form the neural tube, which suggests that these mesenchymal cells are deposited directly into the matrix-filled spaces, and remain there, rather than migrating ventrally from a more dorsal location, as has often been inferred in the literature. It is also noteworthy that these cells appear to emerge from the elevating neural fold epithelium below a transient groove on the epithelium's outer surface, which bears a remarkable resemblance to the primitive streak-the site where, earlier in development of amniote embryos, mesodermal cells originate from the embryonic epiblast during gastrulation [ Fig. 11 ; see also Waterman (1976) ].
Although Nichols referred to these cranial mesenchymal cells as "Neural Crest"-based on Hörstadius' (Hörstadius, 1950) operational definition-this interpretation was revisited by Breau et al. (2008) , who showed that mesenchyme emerges from E-cadherin-expressing non-neural epithelium of the lateral neural folds of mouse embryos and enters directly into what becomes the branchial arches [ Fig. 13 ; see Breau et al. (2008) ; compare Fig. 10 ]. Since this neural fold epithelium appears to be phenotypically distinct from the epithelium of the dorsal ridges, and since mesenchymal cells appear to emerge from the epithelium well before the authentic Neural Crest forms, the idea that these early mesenchymal cells originate from the Neural Crest was again called into question.
In a recent effort to assess whether mesenchymal cells that initially populate the developing branchial arches originate from a domain of neural fold epithelium distinct from the Neural Crest, DiI was deposited on the outer surface of the neural fold epithelium lateral to the dorsal ridges before they had fused to form the neural tube (Lee et al., 2013b) . Care was taken to deposit the dye only on superficial cells of the epithelium, and not to inject it beneath the epithelium Fig. 9 . After epithelial-mesenchymal transition (EMT) of Neural Crest epithelium, Neural Crest-derived mesenchymal cells enter the Migration Staging Area (MSA)-an ECMcontaining interstitial space delimited by neural, epidermal and "at trunk axial level" somite epithelia. Left: Fate-restricted and partially fate-restricted Neural Crest-derived cells (see also Fig. 22 ) reside in close proximity and can interact with each other in the MSA before they disperse on interstitial migration pathways. Initially, some early migrating neurogenic and gliagenic cells move between epithelial somites to contribute to components of the autonomic nervous system (top diagram). After the sclerotome portion of the epithelial somites undergoes EMT, Neural Crest-derived neurogenic and gliagenic precursors begin to migrate ventrally amongst these somite-derived mesenchymal cells and, ultimately, coalesce to form dorsal root ganglia (middle diagram). Finally, Neural Crest-derived pigment cell precursors migrate on a dorsolateral pathway (bottom). Fate-restricted precursors that fail to disperse in a timely way on an appropriate migration pathway appear to undergo apoptosis (dashed circles). where existing mesenchymal cells or underlying neural epithelium might be unintentionally labeled. With this labeling protocol, DiIlabeled mesenchymal cells that were eventually detected in underlying spaces, could have originated by EMT only from the superficial epithelium itself. The results convincingly demonstrated that the labeled mesenchymal cells, which derived from the lateral nonneural epithelium (Fig. 14) , were present in the matrix-filled interstitial spaces beneath the neural fold epithelium. Importantly, these results differed from those of earlier cell tracking studies (Kulesa and Fraser, 2000) in which cells marked by injecting DiI into the lumen of the closed neural tube revealed an extensive later migration of labeled cells into the branchial arches. We suggest that many of the latemigrating cells seen in the posterior branchial arches were, most likely, Neural Crest-derived neurogenic precursors of the enteric nervous system on their migration pathway into the developing gut [see Weston (1983, 1985) ]. In contrast, DiI marking of cells on the surface of the lateral non-neural epithelium of the neural fold confirmed previous conclusions (Breau et al., 2008) , and were consistent with the initial inferences of Nichols (Nichols, 1981 (Nichols, , 1986 . Moreover, the time-lapse analysis of DiI-labeled cells initially present in the lateral non-neural epithelial domain of the avian neural fold further confirmed that, although there is some dorsal movement of parts of this epithelium as the folds elevate and the lateral non-neural epithelium overlaps the neural epithelium in the dorsal ridges, in avian and mammalian embryos, many if not most of the mesenchymal cells that emerge from this epithelium enter directly and progressively into the underlying ECM-containing interstitial spaces [Figs. 12 and 13 ; also see Suppl. Movie in Lee et al. (2013b) ; http://dev.biologists.org/ content/140/24/4890.full.pdfþ html?with-ds=yes]. These cells do not appear to migrate ventro-laterally from more dorsal locations, as had been inferred and described in the classical and "neo-classical" literature [see, for example, Fig. 2 in Imai et al. (1996) ; Noden (1991); Fig. 1 in Dupin et al. (2010) ; and the poster insert in the prominent review by Mayor and Theveneau (2013) ]. It is not yet clear if the same progressive emergence of mesenchymal cells occurs during amphibian neurulation, largely because the process has not been examined at appropriate spatial resolution or at appropriately early stages of neural fold elevation. However, we predict that mesectoderm formation in this system will resemble the events in the cranial neural folds of avian embryos, and might also occur in the trunk neural folds, where early-emerging mesenchyme from lateral non-neural epithelium of the neural folds might be expected to contribute to dorsal fin connective tissue.
Neural Crest epithelium and lateral non-neural epithelium of neural folds are phenotypically distinct As suggested above, the cranial neural folds and the trunk neural tube are structurally different, and it would be misleading to assume Fig. 10 . Mesectodermal cells appear progressively in the mesenchyme adjacent to the non-neuronal epithelium during cranial (midbrain/rostral hindbrain) neural fold elevation. Transverse sections of neural folds from 3-12 somite embryos (noted in the corresponding tracings of the photographs) are reproduced at the same magnification and aligned relative to the developing pharynx to illustrate progressive stages of neural fold elevation. The embryos had been fixed to preserve matrix components produced by mesectodermal cells, which allows the cells to be selectively and differentially stained with Toluidine blue. Note that darkly-stained cells appear to emerge from the epithelium, and are left behind in the underlying interstitial space as the dorsal ridges of the neural folds elevate toward the embryonic midline, eventually to fuse and form the neural tube. These mesenchymal cells presumably proliferate rapidly to fill the interstitial space, which we suggest becomes the functional equivalent, at cranial axial levels, of the Migration Staging Area (MSA) illustrated in Fig. 9 that the two embryonic epithelia are developmentally comparable tissues when mapping their developmental potential. Before we discuss this assertion further, it will be useful to consider three salient issues: (1) that Neural Crest and lateral non-neural epithelia of the cranial neural folds are phenotypically different; (2) that the latter shares cellular phenotypes with mesodermally derived somite epithelium; and (3) that the EMT that occurs in these two epithelial domains are temporally and spatially distinct events that result in the emergence of independently motile, but developmentally distinct, mesenchymal cell populations.
Cadherin expression patterns differ in neural and non-neural epithelial domains of the cranial neural folds
The most striking difference between the medial neural and the lateral non-neural epithelia is that the non-neural epithelium expresses E-cadherin at high levels, whereas the dominant adhesion protein in the adjacent neural epithelium is N-cadherin [Figs. 4 and 5; Breau et al. (2008) ; Lee et al. (2013b) ; Weston et al. (2004) ]. We have already suggested how these two cadherins might play a crucial role in the initial segregation of neural and epidermal epithelia during neurulation.
These two epithelial domains of the early cranial neural folds can be distinguished also by other molecular expression patterns. Molecular markers of EMT and of the subsequent dispersal of mesenchymal cells [such as MMPs (Fig. 8) , Snail, FoxD3, and Sox9] are coexpressed with E-cadherin in the non-neural epithelium of the cranial neural folds. Yet, these expression patterns are essentially absent in the trunk neural tube as well as in the neuroepithelial domains of the cranial neural fold that is positive for N-cadherin and Sox1 [see Lee et al. (2013b) ; Fig. 5 ].
Fibronectin (FN)
Trunk Neural Crest-derived cells, present in the outgrowths from explanted neural tube segments in vitro, do not produce FN (Newgreen and Thiery, 1980; Rovasio et al., 1983) . However, two distinct populations of cells are present in outgrowths from cranial neural fold explants (Newgreen and Thiery, 1980) . The initial outgrowth of cells with fibroblastic morphology is seen to produce FN, whereas a second population of cells, with a distinct small stellate morphology in the same culture conditions reminiscent of cells in the outgrowth of trunk neural tube explants, do not express FN. It is tempting to suggest that the former population originates from the lateral non-neural epithelial component of the neural fold explant, whereas the latter arises from the Neural Crest epithelium, which eventually segregates from the dorsal neural epithelium of the neural tube. This notion remains to be tested by lineage tracing in vitro (Luo et al., 2003) . Interestingly, although FN expression has been reported to be localized to this dorsal neural fold epithelium [ Fig. 15 ; (Mittal et al., 2010) ], the figures appear to support the idea that FN expression is restricted to the thin epithelium overlying the dorsal ridge of the neural fold, as well as in more ventral non-neural epithelium of the branchial arch, both of which are known to express E-cadherin [ (Breau et al., 2008; Weston et al., 2004) ; compare Fig. 4 with Fig. 15) ].
Integrins
The roles of integrins-receptors of various ECM components, including FN, used by migrating Neural Crest-derived cells-are bafflingly complex [see McKeown et al. (2013) ]. However, the integrins expressed in the two epithelial domains of the neural fold appear to be distinct. Integrin αvβ3, for example, is expressed in lateral neural fold epithelium but does not appear to be expressed in the thickened neural epithelium of the neural folds or by authentic trunk Neural Crest-derived cells. In contrast, authentic Neural Crest-derived cells seem to depend on the function of β1-containing integrins for the normal development of neural derivatives [(Alfandari et al., 2003; Breau et al., 2009 Breau et al., , 2006 Pietri et al., 2004) ; see also McKeown et al. (2013) and Wehrle-Haller (2006) ].
Mesodermal markers
Other gene products characteristic of mesodermally derived cells are also expressed in the cells of the lateral non-neural epithelium and in cranial mesenchyme. One such gene product encodes a proteoglycan link protein that is characteristic of chondrogenic cells [Fig. 16; Colas and Schoenwolf (2001) ] and appears specifically in the lateral neural fold epithelium, which is known to co-express E-cadherin, but not in the medial neural domain of the cranial neural folds. Fig. 11 . A transient groove in the forebrain-midbrain neural fold of a 5-somite mouse embryo resembles the embryonic primitive streak and appears to be the site of emergence of mesectodermal cells into the interstitial space underlying the elevating cranial neural folds. The photographs labeled 6A and 6B are SEM images of forebrain (FB)-midbrain (MB) neural folds. The photograph labeled 8B is a parasagittal section of a slightly younger (4-somite) embryo, roughly corresponding to the region indicated by the dashed outline in 6B. Notice the differentially-stained cells that seem to enter the interstitial space below the groove denoted by the arrow in 6B and 8B. It is important to emphasize that this apparent involution process occurs well before the dorsal ridges of the neural folds fuse to form the dorsal epithelium of the neural tube, from which "authentic" Neural Crest epithelium will eventually be partitioned. Source: Reproduced from Nichols (1981) with permission from Development, The Company of Biologists.
Two genes, characteristic of mesodermally derived skeletogenic cells, are particularly informative for distinguishing the two epithelial domains of the neural folds. One gene encodes PDGFRα (Takakura et al., 1996; Weston et al., 2004) and the other encodes the regulatory protein, Twist (Gitelman, 1997) . PDGFRα is clearly co-expressed with E-cadherin in the non-neuronal epithelial domain of the cranial neural folds (see wholemount embryo and panel bʺ in Fig. 4) , and in branchial arch mesenchyme. Twist is also expressed in the mesenchymal cells that enter the adjacent branchial arches [ Fig. 17 ; (Alfandari et al., 2003; Gitelman, 1997; Soo et al., 2002) ]. Analyses of the expression and function of PDGFRα and Twist have been particularly useful in defining the properties of skeletogenic mesenchyme in the head and branchial arches of vertebrate embryos. For example, the Patch mouse mutant (Grüneberg and Truslove, 1960) , which harbors a deletion in the gene encoding PDGFRα (Stephenson et al., 1991) , was initially thought to be potentially informative with respect to lineage segregation within Neural Crest-derived cells, since it affected the development of both melanocytes and craniofacial skeletal derivatives (Morrison- . A detailed analysis of the developmental defects in embryos homozygous for this mutation, however, revealed that it adversely affects somite development as well as skeletal and connective tissue structures derived from mesectoderm, including the craniofacial skeleton, corneal stroma, the cardiac outflow tract, and mesenchyme components of glandular tissue. In contrast, no cell-autonomous defects were observed in neural or pigment derivatives of the Neural Crest in these mutant embryos (Morrison- Schatteman et al., 1992; Wehrle-Haller et al., 1996) .
As with the loss of PDGFRα function, the loss of Twist function causes defects in branchial arch formation, but no changes in "authentic" Neural Crest derivatives were noted (Soo et al., 2002) . Such "paradoxical" phenotypes in the two mutants would not be expected if, as predicted, the mutation occurred in a gene that functioned in a common Neural Crest-derived precursor of neural, pigment and skeletogenic lineages. Instead, the findings from these studies support the inference that skeletogenic mesenchyme in the head and branchial arches originates primarily, if not solely, in an epithelial domain of the cranial neural folds that is spatially, temporally, and developmentally distinct from the authentic Neural Crest. This inference was finally confirmed by careful cell lineage marking studies that discriminated between cells originating from the two epithelial domains [ Fig. 14; (Lee et al., 2013) ].
A Lateral non-neural epithelial domain of the cranial neural folds-"Metablast"-is developmentally distinct from the epithelial neural crest
Lineage marking studies
Schilling and Kimmel (Schilling and Kimmel, 1994) originally reported that what they called "premigratory Neural Crest cells" already included fate-restricted cranial and branchial arch skeletogenic cells that had dissociated from its originating epithelium. Surprisingly, although detailed lineage marking experiments were performed (Fig. 18) , the location of a common precursor for mesectoderm and other Neural Crest derivatives was not explicitly identified. What the tabulated results in this figure do show, however, is that skeletogenic cells arise from an epithelial domain that is spatially distinct from the domain that gives rise to neurogenic and melanogenic derivatives of authentic Neural Crest (see also Fig. 19 ). Consistent with this conclusion, these skeletogenic cells do not appear to express the Crestin gene product, which has been posited to be a "pan-Neural Crest" marker in zebrafish embryos (Luo et al., 2001; Rubinstein et al., 2000) , and which is expressed by Neural Crest-derived cells and in their neural, glial, and pigment cell derivatives that reside in the MSA of amniote embryos.
Gene regulatory networks distinguish two epithelial domains
The skeletogenic mesenchyme that ultimately enters the nascent pharyngeal arches gives rise to skeletal components of the jaw and gills and is thought to up-regulate mesectoderm-specific genes such as dlx2a and fli1a (Brown et al., 2000) , which are components of a regulatory pathway that also includes the characteristic mesodermal marker, Twist1 (see above). Consistent with this inference, the function of Twist1 in mice is required for normal differentiation of cranial skeletal structures and cardiac outflow track connective tissue (Soo et al., 2002; Vincentz et al., 2013) . It should be noted that, based on their earlier work on the development of the cardiac outflow track (Vincentz et al., 2008) , Vincentz and coworkers considered the possibility that loss of Twist function results in a change in cell fate from mesectodermal to neural in cardiac Neural Crest-derived cells. Their results seem to suggest that Twist function can act to repress sympathetic neural regulatory pathways in post-migratory cells by antagonizing BMP targets. However, because these lineage markers do not distinguish Neural Crest-derived cells from that of mesenchymal cells that precociously enter embryonic interstitial spaces after emerging from the lateral non-neural epithelium of the cranial neural folds, it cannot yet be known which cell population is affected by altered Twist function.
Recently, an impressive series of genetic marking and perturbation studies in zebrafish embryos by Das and Crump (Das and Crump, 2012) have provided compelling evidence for the gene regulatory pathway illustrated in Fig. 19 . In this pathway, Twist1 is expressed in mesectoderm precursors and functions to promote Fli1a and Fgf function, which, in turn, regulate Dlx2a function and leads to mesectoderm differentiation into jaw and gill cartilages. In contrast, BMP signaling in an adjacent epithelial domain [see also Aybar and Mayor (2002) ] promotes Id2a function, which suppresses Twist1. Although the gene regulatory pathway inferred by these authors might, as they suggest, account for the segregation of skeletogenic cells and cells with neurogenic potential from a common Neural Crest-derived lineage precursor, their proposed pathways do not exclude the possibility that two distinct epithelial domains can be established, and that the boundary between the two domains can be maintained by BMP signaling [see also the thoughtful discussion in Kanzler et al. (2000) ]. Indeed, their suggested regulatory mechanism seems to provide a clear way to establish and maintain such adjacent epithelial domains with distinctly different developmental potentials and fates.
Another compelling paper from the same laboratory (Cox et al., 2012) suggests an epigenetic mechanism for establishing mesoderm-like developmental potential in the epithelium that produces the mesectoderm precursors of the vertebrate head. Their proposed mechanism (Fig. 20) involves modification of Fig. 13 . Ht-PA-Cre-expressing cells emerge directly into underlying embryonic interstitial spaces from non-neural epithelium that co-expresses E-cadherin. Sections through midbrain neural folds of an e8 (4-5 somite) embryo. (C, G) Red arrowheads indicate cells of the non-neural epithelium that co-express Cre and E-cadherin. White arrowheads mark instances of Cre-expressing mesenchyme that also expresses weak cytoplasmic E-cadherin immunoreactivity. Blue arrowheads show cells that appear to be down-regulating cell-surface E-cadherin during epithelial to mesenchymal transition (EMT), and presumably, as a consequence (Dady et al., 2012) the chromatin structure with histone variant H3.3. Although the authors still refer to "cranial Neural Crest" as the origin of the mesectoderm and the target of this modification, their model, again, does not exclude the possibility that such an epigenetic event could establish a distinct epithelial domain adjacent to authentic Neural Crest epithelium at early developmental stages of zebrafish development.
The non-neural domain of cranial neural folds should be explicitly distinguished from the Neural Crest
Several attributes of the lateral non-neural epithelium suggest that its developmental potential differs from that of Neural Crest: (1) this epithelial domain expresses phenotypic traits characteristic of mesoderm; (2) when this domain undergoes EMT in amniote embryos, mesenchymal cells appear to undergo involution through a transient structure that bears remarkable similarity to the primitive streak (or blastopore) and appears at an earlier developmental stage in the embryonic epiblast [ Fig. 11 ; (Nichols, 1981 (Nichols, , 1986 ]; and (3) the mesenchymal cells that result from this involution express phenotypic traits characteristic of somite-derived mesenchymal cells at trunk axial levels.
To help distinguish the neural epithelium in the dorsal ridges of the neural fold from lateral cranial neural fold epithelium [previously called "paraneural" epithelium; see Johnston (1966) ; Fig. 15. Fibronectin (FN) is expressed by cells in the non-neural epithelial domain of the cranial neural folds. (D) In situ hybridization shows that FN mRNA is expressed in the dorsal ridges of the neural fold in whole mount 8-10 somites mouse embryos (arrows), as well as at more rostral axial levels. (E) Transverse sections reveal that this expression is present both in lateral ectoderm associated with the pharynx and in the dorsal ridges of the neural fold. The enlargement of the dorsal ridge region (dashed rectangle) reveals that expression is restricted to lateral non-neural epithelial cells closely overlying the neural epithelium. Asterisks mark FN mRNA expressed by the dorsal neural ectoderm (long arrow in the inset) and the surface nonneural ectoderm (arrowhead in inset). (F) Consistent with this interpretation, FN immunostaining (green) in the dorsal ridge is associated with TFAP2A-positive cells (arrow, neural; arrowhead nonneural; inset). These cells are considered to originate from "cranial Neural Crest" but are more likely to have emerged from overlying non-neural (Metablast) epithelium (compare the pattern of E-cadherin staining seen in similar histological sections in Fig. 4B , C, and the E-cadherin/Snail co-expression in Fig. 5C ). Abbreviations: A, atrium; NT, neural tube; ec, endocardium; g, gut. Source: Reproduced from Mittal et al. (2010) with permission from Elsevier. Copyright © 2010 Elsevier Ireland Ltd. All rights reserved In Xenopus embryos, expression of the XTwist gene product appears in head and branchial arch mesenchyme, and in mesodermally-derived structures, but not in authentic Neural Crest derivatives. Abbreviations: Wd, wolfian-duct; pn, neural plate; e, eye; ot, otic vesicle. http://dx.doi.org/10.1016/S0012-1606(03)00277-X. Source: Reproduced from Alfandari et al. (2003) with permission from Elsevier. Copyright © 2003 Elsevier Inc. All rights reserved Weston (1970) ] and to emphasize the distinct phenotypic and functional attributes of this latter epithelial domain, we have given this latter epithelium a new name, "Metablast" (meta-; "occurring later than, or in succession to [Epiblast]") (Weston et al., 2004) ; see also Breau et al. (2008) . Unlike cells derived from dorsal neural epithelium, the so-called Metablast-derived cells have now been Fig. 18 . Putative "premigratory" Neural Crest cells in the head of early zebrafish embryos are fate restricted. (A, B) Although the authors define these "premigratory" mesenchymal cells as "Neural Crest", their actual origin is not clear. Operationally, tiers of cells at or near the surface of the epithelium lateral to the neural keel-designated by the numbers in the region outlined on the Nomarski optics photograph of a live 12-h embryo (A) and enlarged in (B), and determined by counting cell diameters between a labeled cell and the lateral margin of the "premigratory" mass-were injected with a lineage tracing dye and the developmental fates of labeled cells were followed. Presumably, these numbered tiers proceeded from lateral to medial along the surface of the mass of cells designated "nc" in the accompanying transverse section. Whatever their actual origin, the tabulated results clearly demonstrate that skeletogenic cells (designated C in the Table) arise from a lateral epithelial domain that is spatially distinct from the domains that give rise to the neurogenic (N) and melanogenic (P) derivatives of authentic Neural Crest. CT, connective tissue; U, unknown or undifferentiated. Source: Reproduced from Schilling and Kimmel (1994) with permission from Development, The Company of Biologists Fig. 19 . Distinct molecular regulatory pathways establish and maintain Neural Crest and ectomesenchymal epithelial domains. This regulatory scheme was originally proposed by Das and Crump (2012) as a way to establish a multipotent cranial Neural Crest population (at 12 h), and then a population of ectomesenchyme precursors (at 16 h), after they "delaminate from the neuroepithelium and migrate away from the source of BMP signal." However, based on inferences summarized in Fig. 18 from Schilling and Kimmel (1994) , it is not clear if such cells actually ever delaminate from neuroepithelium. Moreover, as indicated in the portion of the scheme illustrated here, this same regulatory mechanism can equally well account for the establishment and maintenance of distinct, contiguous epithelial domains, Neural Crest and Metablast, regulated by precisely localized BMP signaling. http://dx.doi.org/10.1371/journal.pgen.1002710. Source: Adapted from Das and Crump (2012) Fig. 20 . An epigenetic mechanism to establish a distinct epithelial domain, like Metablast, with skeletogenic potential. This regulatory scheme, also proposed by members of the Crump laboratory (Das and Crump, 2012) , suggests that altering chromatin structure by H3.3-dependent histone replacement could provide a way for a developmentally distinct epithelial domain with skeletogenic potential to be established in an ectodermal epithelium. Significantly, the authors acknowledge that the extent to which ectomesenchyme derivatives (e.g., head skeleton) and nonectomesenchyme derivatives (e.g., pigment, glia and neurons) derive from a common multipotent precursors remains unresolved. http://dx.doi.org/10.1371/ journal.pgen.1002938. Source: Reproduced from Cox et al. (2012) shown by lineage tracing to be a significant source of branchial arch mesenchyme [Fig. 14; (Lee et al., 2013b) ]. Accordingly, rather than the precocious and prolonged process of emergence of Neural Crest-derived mesenchymal cells that was previously thought to occur at cranial axial levels, the early segregation of Metablastderived mesenchyme might more informatively be considered a delayed morphogenetic event resembling gastrulation. This morphogenetic process, like gastrulation, produces a distinct population of mesenchymal cells with cellular phenotypes and developmental fates similar to those of mesoderm. As suggested schematically in Fig. 21 , this population of cells enters the cranial MSA and the branchial arches before authentic Neural Crestderived cells do so, and thereby can possibly set the stage for subsequent migration of Neural Crest-derived cells into and through the branchial arches.
The reinterpretation of the temporal events suggested in Fig. 21 conforms with the inferences (1) that classical experimental results were derived from cell/tissue marking and transplantation that involved both the lateral neural fold (Metablast) epithelium and the dorsal ridges of the neural folds, which contained authentic Neural Crest epithelium; (2) that skeletogenic mesenchymal cells segregate from the Metablast domain of the lateral Fig. 22 . After epithelial to mesenchymal transition (EMT), cells that emerge from neural fold epithelial domains undergo progressive fate-restriction. In this scheme, based on various lineage analyses, and first proposed about 25 years ago, mesectodermal cells with skeletogenic and connective tissue developmental potential (newly-labeled MB for Metablast) are shown segregating precociously from cranial neural fold epithelium. Subsequently, fate-restricted neurogenic precursors, populations of partially restricted neuro-glial, and glia-melanocyte precursors, and finally, fate-restricted glial and melanocyte precursors appear within the Neural Crest-derived cell populations. Although they reside in close proximity in the MSA (see Fig. 9 ), these subpopulations can interact, and respond to specific environmental cues that can cause them to survive or undergo lineage restrictions or apoptosis, proliferate, or initiate directed migration on appropriate interstitial pathways. Dashed lines indicate contact-mediated interactions between fate-restricted neurogenic precursors and partially-restricted glial-melanocyte precursors that elicit gliagenesis. Similar interactions between partially-restricted glial and neuron progenitors can also elicit neurogenesis (see Dyachuk et. al., 2014; Espinosa-Medina et al., 2014) . Abbreviations: a, autonomic neuronal precursors; A, adrenergic neurons; C, cholinergic neurons; cnf, cranial neural folds; E, enteric neurons; em, ectomesenchyme; G, Schwann sheath and other peripheral glia; M, melanocytes; MB, Metablast; nc, trunk Neural Crest (and cranial Neural Crest after fusion of the neural folds in the dorsal midline); nf, neural folds after the ectomesenchymal subpopulation has segregated; nn nonneurogenic crest cells; np, neurogenic precursors; SNp, primary sensory neurons; SN, other sensory neurons. Redrawn from Weston (1991) with permission from Elsevier. Copyright © 1991 by Academic Press, Inc. All rights of reproduction in any form reserved. cranial neural folds before cells with Neural Crest potential have been partitioned from the neural epithelium [see Figs. 12 and 13; Lee et al., (2013b) ]; and (3) that authentic Neural Crest-derived cells require appropriate FN-containing matrix substrata before they enter adjacent interstitial spaces. The recent report that trunk Neural Crest-derived cells in the zebrafish embryo are not the source of fin skeletal components (Lee et al., 2013a) is also consistent with the generalization that authentic Neural Crestderived cells lack skeletogenic potential.
To be recognized as a valid alternative source of skeletogenic cells, the proposal that Metablast epithelium is a distinct embryonic structure from authentic Neural Crest must address some significant counter-arguments
There are, as one might expect, a number of plausible objections that have been raised against our suggestion that authentic Neural Crest is not the source of skeletogenic mesenchyme.
The inference that trunk Neural Crest-derived cells have skeletogenic potential is based on problematic cell culture results.
McGonnell and Graham (Graham, 2004; McGonnell and Graham, 2002) reported that cultured avian trunk Neural Crestderived cells could give rise to cells exhibiting phenotypes characteristic of skeletal/connective tissue. This seemed to suggest that Neural Crest-derived cells do have skeletogenic potential. However, in these experiments, the source of "Neural Crest" was actually cultured neural fold epithelium from early avian embryos. This neural fold epithelium was explanted and maintained in vitro at high cell densities for prolonged times in an enriched culture environment. Consequently, in such long-term cell culture experiments, it is likely that rare mesenchymal stem cells (Komada et al., 2012; Takashima et al., 2007) in the cultured population are "amplified" by environmental conditions that promote their survival and proliferation. Thus, it is difficult to know the actual source and the developmental history of the embryonic cells that gave rise to the reported phenotypes. So, although the trunk Neural Crest cannot be excluded as a source of skeletogenic cells, it seems unlikely that these cells normally have skeletogenic potential. Subsequently, it was suggested that Neural Crestderived cells respond to localized skeletogenic signals, such as FGF, when they enter the Branchial Arches (BAs) (Blentic et al., 2008) . Although this study carefully describes the localization of such signaling molecules in avian and zebrafish embryos, and reports that a Sox10-expressing, Neural Crest-derived cell population is present in the BAs, their study lacked the temporal and spatial resolution needed to exclude the possibility that skeletogenic cells originated from cells that had precociously entered the BAs before the onset of the migration of Neural Crest-derived cells.
Cloning studies suggesting that neural and mesectodermal derivatives have a common precursor are technically flawed.
The results of limit-dilution cloning studies in vitro initially appeared to refute our suggestion that neural and mesectodermal derivatives do not originate from a common neural crest-derived precursor (Baroffio et al., 1991; Ito and Sieber-Blum, 1991) . These cell culture results, however, are also subject to uncertainties caused by cell culture and analytic protocols. These concerns have been previously discussed (Breau et al., 2008; Henion and Weston, 1997; Weston et al., 2004) and are summarized as follows:
(1) Neural Crest-derived cell populations used for limit-dilution clonal cultures were obtained from primary cultures of cells derived from neural fold explants in rich culture medium. These initial explants of mesencephalic neural folds would include superimposed neural and non-neural epithelia, which are difficult or impossible to separate by microsurgery. (2) After primary culture, enzymatically dissociated cells were diluted and cultured at clonal densities in complex culture medium on feeder cell substrata. (3) As with all such culture protocols, the culture conditions not only result in the enrichment of rare cells with stem cell abilities, but also, very likely, induced changes in the developmental potential of responsive cells. (4) As the overall cloning efficiency was not assessed, and since not all clones were analyzed for their cellular phenotypes, the survey of the developmental potential of the clonal progenitors was necessarily biased (see the Fate-restriction and lineage diversification in Neural Crest-derived and Metablast-derived cell populations section) and probably overestimated the proportion of skeletogenic precursors in the population. (5) Finally, the actual data, carefully and responsibly summarized in Table 1 of their original paper (Baroffio et al., 1991) , showed dramatic variations in clone size generated by progenitors under identical culture conditions, and the very few clones that contained multiple Neural Crest-derived phenotypes as well as mesectoderm-like derivatives were exceptional in that they were two or three orders of magnitude larger than clones that lacked multiple derivative classes.
As with the experiments of McGonnell and Graham, these results could be explained by the selection of a rare mesenchymal stem cell clonal progenitor [see Komada et al. (2012) ]. Although a follow-up paper (Dupin et al., 2010) still did not provide estimates of cloning efficiency and, unfortunately, did not include information about the sizes of clones that contained both skeletogenic and neural cell types, the authors reasserted their conclusion that cells with neural, melanocytic, chondrogenic and osteogenic potential originated from a common Neural Crest-derived clonal precursor. This conclusion might be valid for cells from mesencephalic neural folds after prolonged culture in vitro. However, their cloning methods do not provide an unbiased survey of the kinds and proportions of fate-restricted precursors in the original cultured cell population (see the Fate-restriction and lineage diversification in Neural Crest-derived and Metablast-derived cell populations section) nor do they provide any insight concerning where such cells originate in vivo. Consequently, their results cannot exclude the possibility that clones containing skeletogenic mesectoderm originate from a developmentally distinct precursor within cranial neural fold epithelium.
The conclusion that regeneration of Neural Crest cells after experimental ablation accounts for the presence of elements of head skeleton ignores a more parsimonious explanation.
The presence of head skeletal components has been reported after Neural Crest ablation at mid-and hindbrain axial levels (Scherson et al., 1993) . This result might be thought to support the idea that skeletogenic precursors do not originate from Neural Crest. However, the authors accounted for the presence of skeletal elements in the head by proposing that Neural Crest-derived skeletogenic cells regenerated from neuroepithelial cells remaining in the lateral and ventral neural tube after ablation. Thus, Scherson and coworkers ablated the dorsal neural tube at mid-and hindbrain axial levels before the onset of Neural Crest migration. They reported that the DiI-labeled mesenchymal cells that emerged after ablation from lateral and ventral neural tube epithelium followed normal migratory pathways, and that branchial arch structures were present in such operated embryos. They concluded that neuroepithelium could regulate their normal CNS fates to form Neural Crest derivatives, including skeletogenic mesenchyme. This result [see also Saldivar et al. (1997) ] is based on the assumption that Neural Crest is the sole source of skeletogenic mesenchyme and seems to confirm that Neural Crest-derived cells produce skeletal elements in the branchial arches. However, it should be noted that these experiments did not show that DiI-labeled cells were present in the branchial arch structures observed in operated embryos. Nor did the authors consider the possibility that the dorsal neural tube ablations described in these papers did not remove the lateral non-neural epithelium or the mesenchymal cells that had precociously emerged from it. Therefore, since such mesenchyme is known to precociously enter into the branchial arches (Breau et al., 2008; Lee et al., 2013b; Pietri et al., 2003) , the possibility cannot be excluded that the branchial arch structures, which are thought to arise from regenerated Neural Crest-derived cells, were actually formed from mesenchymal cells originating from embryonic tissue that had not been removed in the operated embryos but were retained in the interstitial spaces. This alternative is also consistent with later reports from the same laboratory [see Fig. 1 in Baker et al. (1997) ] that lateral non-neural epithelium transplanted in these experiments included mesenchymal cells that closely associated with, and likely originating from, the grafted epithelium.
Putative genetic markers of NC, previously thought to be expressed initially only in dorsal epithelium of the nascent neural tube, are also expressed in lateral non-neural (Metablast) epithelium of the neural folds.
Finally, it has been reported that skeletogenic mesenchyme is robustly labeled in the head and branchial arches when cells are specifically marked in transgenic mice by the expression of Crerecombinase driven by Wnt1 or Ht-PA-Cre promoters. Since Wnt1 has been assumed to be specifically and exclusively expressed in the dorsal neural epithelium, it was inferred that these skeletogenic cells originated from Neural Crest-derived cells (Jeong et al., 2004; Jiang et al., 2000; Pietri et al., 2003) . A closer analysis of the expression pattern of Wnt1, however, has revealed that it is expressed not only in the medio-dorsal neural epithelium of the neural tube but also in the lateral non-neural epithelium of the neural folds (Breau et al., 2008) . Likewise, as previously mentioned, the Ht-PA-Cre promoter would normally cause all cells that disperse within interstitial spaces to be intrinsically marked, regardless of their origin. Consequently, the assumption that Neural Crest-derived cells are specifically and exclusively labeled in these transgenic embryos is not valid, unless, of course, it is also assumed that the lateral non-neural and medio-dorsal neural epithelia are developmentally equivalent.
In summary, we believe that, even after considering these counter-arguments, it is appropriate to question whether the Neural Crest is the source of mesenchyme with skeletogenic and connective tissue (smooth muscle, odontogenic, etc.) potential. We also believe that it is still appropriate to consider the heuristic alternatives: (1) that these mesoderm-like derivatives originate from a distinct non-neural epithelial domain of the neural folds in vertebrate embryos, and (2) that this epithelium undergoes precocious EMT to produce mesenchyme that enters adjacent interstitial spaces before migration of Neural Crest-derived cells begins.
Fate-restriction and lineage diversification in Neural Crestderived and Metablast-derived cell populations
Even if, as we have suggested, the epithelial Neural Crest is not the source of common precursors of both skeletogenic and neurogenic cell lineages, these cells still give rise to a remarkable diversity of cell types. Accordingly, if our suggestion were accepted that skeletogenic mesenchyme does not originate in the Neural Crest, we would no longer need to postulate molecular regulatory mechanisms that would account for the appearance of both neural and skeletogenic phenotypes from a common precursor. Rather, we could more tractably address and eventually understand the mechanisms that progressively restrict the developmental potential of Neural Crest-derived cells to produce the still remarkably diverse repertoire of neural, glial, glandular, and pigment cell phenotypes diagramed in Fig. 22 .
The starting point of such an analysis is the consensus that the cells in the dorsal neural epithelium of the nascent trunk neural tube are developmentally multipotent. This was clearly demonstrated by the results of early lineage studies utilizing DiI as an externally applied marker (Bronner-Fraser and Fraser, 1989) . Although it was initially claimed that this work provided direct evidence of Neural Crest cell pluripotentiality, it now appears more likely that labeled dorsal neuroepithelial cells in the trunk neural tube can give rise to both neural tube and Neural Crest cell types. It is plausible to infer, however, that when the Neural Crest is initially partitioned from the dorsal neural tube epithelium, the cells within this epithelium are multipotent, and eventually produce the remarkable range of neural, endocrine, and pigment phenotypes generally attributed to authentic Neural Crest.
Lineage diversification is forestalled in epithelial cells coupled through gap junctions
It is intriguing to note that the cells of the early Neural Crest epithelium express Cx43, a member of a multigene family encoding connexins (Kumar and Gilula, 1992) . Connexins assemble to form gap junctions, which are thought to mediate the functional coupling of cells within epithelia (Bennett et al., 1991; Bruzzone et al., 1996) , and thereby coordinate cell communication involved in patterning and differentiation during development (Guthrie and Gilula, 1989; Lo, 1996; Warner et al., 1992) . Such gap junction-mediated cell communication exists in the neural tube and in Neural Crest within the dorsal neural tube epithelium (Huang et al., 1998) . Accordingly, it is tempting to speculate that gene activity within such coupled epithelium would be coordinated, and that developmental multipotentiality would be preserved in its cells by preventing differential gene expression within the communicating epithelial domain. Accordingly, we suggest that, while gap junctions and consequent cell coupling are maintained, their homeostatic function would serve as a "governor" to suppress lineage diversification by the coupled cells in the epithelium. This would presumably be mitigated when cells began to dissociate from the epithelium under the control of EMT regulatory pathways (see above). Additionally, one might predict that the efficiency of EMT regulation itself and the resultant emergence of mesenchymal cells from an epithelium would positively correlate with the level of connexin production and the degree of cell coupling within the epithelium. This is exactly the result that was observed and reported in vivo and in vitro (Ewart et al., 1997; Huang et al., 1998) . Cells within Neural Crest epithelia would be expected to remain pluripotent until the regulated events of EMT occurred and epithelial cell coupling was interrupted. This, too, is consistent with reported observations (Bronner-Fraser and Fraser, 1989) .
Fate-restricted NC-derived cells are detected soon after epithelial cells undergo EMT
The progressive restriction of this developmental potential would be predicted to begin only after the onset of EMT and the separation of mesenchymal cells either from Neural Crest or Metablast epithelium. This prediction has been validated in a number of ways. First, monoclonal antibody technology revealed the existence of numerous phenotypically distinct subpopulations of Neural Crest-derived cells in vivo and in vitro (initially reviewed in Weston, 1983 ; see also Ciment et al., 1986; Girdlestone and Weston, 1985; Marusich et al., 1986; Marusich and Weston, 1992) . Likewise, the use of neuron-specific monoclonal antibodies eventually revealed that the cohesive clusters of trunk Neural Crestderived cells, which we had erroneously considered to be homogeneous populations of melanogenic cells (Loring et al., 1981) , also initially contained a subpopulation of neurogenic cells (Vogel and Weston, 1988) . Interestingly, these neurogenic cells were progressively lost when Neural Crest cell clusters were prevented from undergoing timely dispersal on culture substrata in vitro. This loss in closely associated cell populations seems paradoxical since, after dispersing in embryonic interstitial spaces, such neurogenic cells ultimately coalesce to form ganglia in which closely associated neuronal and glial cells differentiate. This paradox was resolved in a series of carefully controlled experiments showing that prolonged cell proximity within nascent Neural Crest cell populations led to apoptosis of neurogenic precursors . These cell interactions, probably mediated through a Notch-Delta signaling pathway, result in selective cell death of neurogenic precursors. The work also showed that neurogenic cells in cultured crest cell populations that had dispersed immediately were not susceptible to contact-mediated death even if close cell interactions were subsequently promoted. Such a mechanism of contact-mediated cell death suggests the intriguing idea that prolonged contact among Neural Crestderived cells in the MSA could serve to selectively eliminate neurogenic precursors that failed to undergo timely dispersal on an appropriate interstitial migration pathway.
Second, although the time when fate restrictions occur within Neural Crest-derived cell populations is still being debated [see McKinney et al. (2013) ], it is still clear that the cell population in the MSA consists of a mixture of fate-restricted and partially restricted cell types [see Fig. 9 ; (Krispin et al., 2010; Nitzan et al., 2013; Thomas and Erickson, 2008) ]. We cannot, in the present review, pursue all the ramifications of the idea that timing of dispersal of developmentally restricted subpopulations of Neural Crest-derived cells affects their fate. Nevertheless, it is important to recognize that fate-restricted subpopulations do exist among crest-derived cells residing in the MSA, and that such distinct subpopulations express specific phenotypic traits that affect their migratory behavior. It is also clear that fate-restricted melanogenic precursors are present in the outgrowth population of crest-derived cells from explanted trunk neural tubes, and that these cells express a characteristic receptor tyrosine kinase, c-kit, in vitro (Luo et al., 2003) . Likewise, we now know that c-kit-expressing melanogenic cells are able to respond to the appropriately localized cognate ligand in vivo, which provides both tropic cues leading to directional migration and trophic support for survival and proliferation of these melanogenic precursors (Harris et al., 2008; Thomas and Erickson, 2009; Wehrle-Haller et al., 2001 , 1996 . Similarly, neurogenic precursors in the Neural Crest-derived population in vitro express cell type-specific receptors, such as the neural cell-specific receptor tyrosine kinase, trk, which would make them responsive to appropriate growth factors localized in the embryonic environment (Luo et al., 2003) ; these receptors are required for neuronal survival in appropriate embryonic locations (Wakamatsu et al., 1998) . It seems reasonable to postulate, therefore, that such cells remain in the MSA until they acquire appropriate receptors for specific localized growth factors as well as whatever lineage-specific integrins (e.g., α1β1 and perhaps αvβ3) are required to enable the recognition of appropriate substrata for locomotion.
Progressively fate-restricted subpopulations appear within NCderived mesenchyme
Remarkably, the time and order of segregation of fate-restricted Neural Crest-derived subpopulations are still poorly understood.
And, of course, this information must be established before we can know when and where to look for appropriate regulatory mechanisms, or to understand how such regulatory mechanisms function. One example of this complex issue is seen in the function of FoxD3, which seems to regulate lineage segregation in trunk Neural Crestderived cell populations. Specifically, the expression of FoxD3 function reportedly favors the maintenance of neurogenic and gliagenic precursors, whereas its down-regulation results in the appearance and subsequent maturation of melanogenic precursors [see, for example, Kos et al. (2001) ; Thomas and Erickson (2009) ].. The function of FoxD3 in the so-called cranial Neural Crest (CNC) is not so clear. Thus, for example, the proportion of gliagenic and skeletogenic cell populations that arise in this population is reportedly altered by the down-regulation of FoxD3 [see Drerup et al. (2009) ]. However, as we have suggested, the CNC population most likely contains both Neural Crest-derived and Metablastderived cells and, unfortunately, the literature in this field has not yet considered the possibility that CNC cell populations actually have a dual origin. Consequently, it is not yet clear whether FoxD3 function regulates the fate restriction of skeletogenic and neural precursors cells within a common Neural Crest-derived precursor population or if there is a dual origin of mesenchymal cells and the regulatory gene actually operates in one distinct precursor population, which, as in the case of PDGFRα (see the Mesodermal markers section), has non-cell autonomous consequences on the appearance of other cell types.
We have previously discussed how limit-dilution cloning studies have suggested the presence of multipotent and developmentally-restricted precursors within crest-derived populations. We have also emphasized, however, that such methods of clonal analysis are fraught with technical problems that prevent unbiased estimates of the kinds and proportions of such precursors in the original population of Neural Crest-derived cells. However, an important advance in the clonal analysis of Neural Crest-derived cells has constructively addressed these problems (Henion and Weston, 1997; Luo et al., 2003) . 5 This modified cloning method allows individual Neural Crest-derived clonal progenitors to be randomly sampled with lineage-tracing dyes in the initial outgrowth from explanted neural tubes. The method does not involve potentially damaging initial harvesting or bulk secondary culture of primary outgrowths, nor does it impose the unnatural conditions encountered by isolated cells trying to survive in an alien culture environment containing unknown and uncontrolled environmental cues. Importantly, the developmental fates of all of the randomly marked cells can be assessed, regardless of the size of the clones that they produce. This approach permitted an unbiased and statistically significant survey of the kinds and proportions of fate-restricted clonal progenitors that are initially present in trunk Neural Crest-derived populations and at intervals after their emergence from the Neural Crest epithelium. The results were remarkably informative: Although a very small proportion (o2%) of the initial Neural Crest cell population was identified as multipotent (neuron-glial; glia-melanocyte) clonal progenitors, nearly half of the randomly sampled cells produced single-phenotype clones. A discrete, fate-restricted neuronal precursor population, producing small clones containing 1-4 cells, could be distinguished before melanocyte and glial precursors were present in the population. Moreover, the presence of fate-restricted progenitors could be inferred with this procedure well before any overt differentiation had occurred. These lineage analyses, along with studies of phenotypically distinct subpopulations present in Neural Crest-derived populations in vitro and in vivo, gratifyingly substantiated earlier speculations about the relative time and order of the segregation of partially and fully fate-restricted precursors [ Fig. 22 ; see Weston (1991) ]. The lineage analyses also provided the incentive to continue to examine the nature and timing of interactions among Neural Crest-derived subpopulations [e.g., Maynard et al. (2000) ; Wakamatsu et al. (2000 Wakamatsu et al. ( , 1998 ; see also Dyachuk et al. (2014) ; Espinosa-Medina et al. (2014) ], which eventually result in the spatially appropriate appearance of PNS derivatives of the Neural Crest. More importantly, similar methods might now be applied to map the details of lineage segregation of the skeletal and connective tissue derivatives of the Metablast epithelium so as to determine its unique role in the development of cranial structures of vertebrate embryos.
Some evolutionary considerations
The conventional notion that cranial skeletal and connective tissue derivatives originate from the Neural Crest has given rise to provocative speculations that this remarkable embryonic cell population was the evolutionary "invention" that led to the formation of the head and neck in craniate vertebrates. In a burst of enthusiasm, Hall (Hall, 1998) even suggested that the Neural Crest epithelium could be considered as a fourth germ layer that allowed unique features of craniates to appear in vertebrate lineages after the evolution of the neural tube and the notochord. This suggestion followed the much-cited publication by Gans and Northcutt (Gans and Northcutt, 1983) , who proposed that Neural Crest was the evolutionary innovation that allowed vertebrates to develop a head. Specifically, they provided the following arguments. First, that following the evolution of the notochord, central nerve tube, and axial musculature, cephalochordates became less sessile, at least during part of their life cycle. Second, that increased axial musculature enabled better pumping by pharyngeal wall muscles, which, in turn, enhanced gas exchange and effective feeding. Finally, that elastic recoil of the pharynx after deformation by muscle contraction would provide a mechanism to optimize pumping. They then heuristically suggested that a novel connective tissue arising in craniate evolution could produce chondromucoid-containing ECM underlying such elasticity in the pharyngeal walls. Although the cachet of the Neural Crest was certainly enhanced by their suggestion that it was the source of this novel tissue, it is compelling to think that the same evolutionary advantages could have been conferred in the chordate lineage by the development of the Metablast as the source of chondrogenic matrix in pharyngeal tissues (see Fig. 15 ). This is consistent with the suggestion (Jeffrey, 2007 ) that a distinct "Neural Crest-like" cell population is present in Ascidians-a vertebrate sister-group-and, in turn, raises important questions about where and how the mesectoderm originated.
We have already discussed the intriguing model posited by the Crump Laboratory (Cox et al., 2012; Das and Crump, 2012) , which provides a plausible mechanism for an ectodermal epithelial domain to acquire mesodermal properties through epigenetic modifications and a localized decrease in BMP signaling (Figs. 20 and 21) . We have also previously speculated that appropriately responsive cells with mesodermal potential might have arrived in the Metablast domain by evading the process of involution from the Epiblast during earlier gastrulation events (Breau et al., 2008; Hatada and Stern, 1994; Weston et al., 2004) . Although well beyond the scope of the present review, it will also be of great interest to pursue the implications of recent work [see, for example, Yan et al. (2005) , and references therein] suggesting that new phenotypes and new developmental potential might evolve in neighboring epithelia as a consequence of the functional diversification of gene orthologues that arose by prior genome duplication early in vertebrate evolution (Yan et al., 2005) . This, in turn, is consistent with our extrapolations to cranial epithelia of (1) the regulatory mechanisms suggested to exist in crest-derived cells by the Crump laboratory (see Figs. 19 and 20 above), (2) the suggestion by Jeffrey (2007) that a distinct tissue source of connective tissue is present in Ascidians, and (3) the recent suggestion that novel regulatory gene function for cartilaginous tissue in early chordates might have been acquired by tissues associated with the central nerve cord of embryos in the ancestral lineage of craniates (Jandzik et al., 2014 ; see also Hall, 1999) .
Final comments
The contents of this review suggest that timing is an essential element in understanding the regulation of Neural Crest development. This includes the time that the lateral epithelium of the cranial neural fold undergoes EMT relative to when Neural Crestderived cells emerge from dorsal neural tube epithelium; the time that fate-restricted subpopulations appear in the Neural Crestderived cell population relative to their emergence from Neural Crest epithelium; and the time that fate-restricted cells remain in the MSA before they disperse on interstitial migration pathways.
Timing has also played an important role in determining what assumptions underlie interpretations of experiments on Neural Crest. To appreciate this more fully, the reader might reflect again on the consequences of accepting the assumption that the tissues comprising cranial and trunk Neural Crest of amniote embryos were equivalent (Le Lievre and Le Douarin, 1975) , or our early assumption that migrating Neural Crest populations were developmentally homogeneous [see Weston (1963 Weston ( , 1970 ]. These implicit assumptions were called into question only when immunological and molecular genetic approaches revealed spatially demarcated domains within the neural folds and phenotypically distinct subpopulations within Neural Crest-derived populations whose cells were otherwise indistinguishable in vitro and in vivo. Most unfortunately, these implicit assumptions led us to ignore the possibility of spatial heterogeneity within this epithelium until it was finally unequivocally demonstrated in the zebrafish embryo (Schilling and Kimmel, 1994) . Until that time, the precise epithelial domains from which developmentally distinct cells emerged were neither recognized nor resolved. Moreover, in the absence of intrinsic phenotypic markers to distinguish epithelial domains within the neural folds, there was no way, nor any incentive, to validate the implicit assumption that the dorsal ridges and the lateral epithelia of the neural folds had equivalent developmental potential, or even to suggest that they might be developmentally different! These assumptions inadvertently obscured the distinction between cells that originated from the dorsal neural epithelium of the neural tube, and cells-possibly with different antecedents and a different developmental history-that emerged from lateral non-neural epithelium of the neural folds.
Parenthetically, it should be noted that the authors understand that the timing of the presentation of our ideas in this review is probably more propitious, or at least less harmful, for our career trajectories than was the case when Julia Platt first dared to suggest that mesoderm-like cell types originated from embryonic ectoderm! Finally, therefore, we suggest that, despite the widely accepted generalizations about the extraordinary developmental potential of Neural Crest-derived cells, the timing might now be right to proceed through Haldane's (Haldane, 1963) temporal stages of dealing with the idea that cranial skeletal mesenchyme and other mesectodermal derivatives originate evolutionarily and developmentally from a distinct epithelial domain of the embryonic neural folds-the Metablast-rather than from the Neural Crest. We are confident that, in the fullness of time, there will be more opportunities to ascertain if, indeed, the putative Metablast epithelium-genetically regulated independently of Authentic Neural Crest-is the source of cells with mesoderm-like skeletogenic ability, as well as the ability to regulate the migration and fate of authentic cranial Neural Crest-derived cells.
